直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • 新闻
  • 飞翰事实
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • 慈善性法律援助
  • 管理层
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

PTAB's Skyrocketing Petition Rate Starts to Stabilize

February 11, 2016

Law360

Since the creation of the Patent Trial and Appeal Board (PTAB) in 2012, the Board has seen a flood of petitions. In just three years, the number of petitions filed jumped from 110 to nearly 1,800. But data shows that the rate is beginning to stabilize. Law360 contacted Finnegan attorney Linda J. Thayer for her thoughts on the rate of petitions at the PTAB over the past few years.

Thayer said, "The PTAB is taking on a vast number of challenges of specious patents and ruling on the validity of patents before substantial costs are expended in district court litigation. It’s playing a substantial role and exactly the role Congress intended for it to play." Thayer also believes that if the Board becomes increasingly efficient in handling AIA proceedings within the one year statutory deadline, more defendants may challenge patents there. "I think the pendency of AIA proceedings will go down, and the PTAB will get to final written decisions sooner. Right now, if a defendant is facing concurrent litigation in Texas or the Eastern District of Virginia, the defendant may think twice before filing an inter partes review because it may not be completed fast enough for the court to grant a stay. But if the pendency of AIA reviews goes down, we could see a small increase in the number of petitions," said Thayer.

Tags

America Invents Act (AIA)

Related Practices

专利局无效程序

PTAB无效程序:双方复审及授权后复审

Related News

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Press Release

普为光电在美国专利商标局获得对嘉兴山蒲的全部10项专利的单方再审申请立案决定后,成功取得新泽西联邦地区法院中止专利诉讼裁定

2026年4月28日

Press Release

Pvtech Achieves Perfect Record at USPTO: Institution of All 10 of 10 Ex Parte Reexamination Petitions Against Patents Asserted by Jiaxing Super Lighting

April 24, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP